3,4-MDO-U-47700

Overview

3,4-MDO-U-47700 is a synthetic opioid analgesic that is structurally related to U-47700, a compound originally developed in the 1970s by Upjohn for potential use as a painkiller. This compound is part of a class of drugs known as designer drugs, which are often created to mimic the effects of controlled substances while avoiding legal restrictions.

Chemical Structure

Chemical structure of 3,4-MDO-U-47700

The chemical structure of 3,4-MDO-U-47700 is characterized by the presence of a methylenedioxy group attached to the phenyl ring of the U-47700 molecule. This modification is believed to alter the pharmacological properties of the compound, potentially affecting its potency and duration of action.

Pharmacology

3,4-MDO-U-47700 acts as an agonist at the mu-opioid receptor, similar to other opioids. This interaction is responsible for its analgesic effects, as well as its potential for abuse and addiction. The compound's exact binding affinity and efficacy at the receptor are subjects of ongoing research.

Legal Status

Due to its structural similarity to U-47700 and its potential for abuse, 3,4-MDO-U-47700 may be subject to legal restrictions in various jurisdictions. Many countries have implemented laws to control substances that are chemically similar to known opioids, in an effort to combat the rise of opioid abuse.

Health Risks

The use of 3,4-MDO-U-47700 carries significant health risks, including the potential for opioid overdose, respiratory depression, and death. As with other opioids, the risk of addiction is high, and withdrawal symptoms can be severe.

Related Pages

• U-47700
• Opioid
• Designer drug
• Opioid epidemic